v3.19.1
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Revenues:    
Royalty income $ 31,243 $ 31,065
Selling, general and administrative expenses 1,300,571 1,247,008
Research and development expenses 313,013 240,493
Loss from Operations (1,582,341) (1,456,436)
Other (Income) Expense:    
Amortization of debt discount 4,569,757
Gain on extinguishment of convertible notes payable (1,524,791)
Interest (income) expense, net (8,615) 210,462
Change in fair value of derivative liabilities 35,623
Total Other (Income) Expense (8,615) 3,291,051
Net Loss (1,573,726) (4,747,487)
Deemed dividend to preferred stockholders (129,141)
Net Loss Attributable to Common Stockholders $ (1,573,726) $ (4,876,628)
Net Loss Per Basic and Diluted Common Share: $ (0.13) $ (0.80)
Weighted Average Number of Common Shares Outstanding: Basic and Diluted 12,267,446 6,133,678

Source